BlackRock Fund Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9.22M | Buy |
1,195,897
+123,726
| +12% | +$954K | ﹤0.01% | 2617 |
|
|
2016
Q3 | $12.3M | Buy |
1,072,171
+232,783
| +28% | +$2.66M | ﹤0.01% | 2342 |
|
|
2016
Q2 | $10.3M | Buy |
839,388
+15,990
| +2% | +$197K | ﹤0.01% | 2394 |
|
|
2016
Q1 | $8.33M | Buy |
823,398
+19,418
| +2% | +$196K | ﹤0.01% | 2461 |
|
|
2015
Q4 | $18.1M | Sell |
803,980
-71,048
| -8% | -$1.6M | ﹤0.01% | 2112 |
|
|
2015
Q3 | $14.5M | Buy |
875,028
+47,619
| +6% | +$790K | ﹤0.01% | 2189 |
|
|
2015
Q2 | $18.6M | Buy |
827,409
+100,028
| +14% | +$2.25M | ﹤0.01% | 2152 |
|
|
2015
Q1 | $18.8M | Buy |
727,381
+19,790
| +3% | +$510K | ﹤0.01% | 2111 |
|
|
2014
Q4 | $15.4M | Buy |
707,591
+41,745
| +6% | +$908K | ﹤0.01% | 2209 |
|
|
2014
Q3 | $12.6M | Buy |
665,846
+4,889
| +0.7% | +$92.5K | ﹤0.01% | 2220 |
|
|
2014
Q2 | $15.4M | Buy |
660,957
+169,818
| +35% | +$3.96M | ﹤0.01% | 2165 |
|
|
2014
Q1 | $16.5M | Buy |
491,139
+41,923
| +9% | +$1.41M | ﹤0.01% | 2102 |
|
|
2013
Q4 | $13.3M | Buy |
449,216
+318,048
| +242% | +$9.39M | ﹤0.01% | 2214 |
|
|
2013
Q3 | $2.01M | Buy |
+131,168
| New | +$2.01M | ﹤0.01% | 3123 |
|